Company Filing History:
10 out of 1,536 
1 out of 15 Years Active: 2009-2014
Title: **Fabio Paleari: Innovating Pharmaceutical Solutions**
Introduction
Fabio Paleari is a prominent inventor based in Monza, Italy, known for his significant contributions to the field of pharmaceuticals. With a portfolio of 11 patents, he has focused on developing innovative compounds aimed at addressing various central nervous system (CNS) disorders and enhancing pharmaceutical compositions.
Latest Patents
Among his latest inventions, Paleari has developed sulfated benzimidazolone derivatives, which possess mixed serotonin receptor affinity. This groundbreaking invention, characterized by a specific compound formula, outlines a process for preparing these compounds and their application as pharmaceuticals in treating CNS disorders. Furthermore, he has worked on selected CGRP-antagonists, detailing the synthesis of these compounds and their use in pharmaceutical compositions. The extensive claims cover various forms of the compounds, including their tautomers, isomers, diastereomers, and acceptable salts, demonstrating his innovative approach to drug formulation.
Career Highlights
Throughout his career, Fabio Paleari has made significant strides in pharmaceutical research and development. He has worked with major companies in the industry, including Boehringer Ingelheim International GmbH and Sprout Pharmaceuticals, Inc., contributing to various projects that emphasize the impact of pharmacological interventions.
Collaborations
Paleari has collaborated with esteemed professionals in his field, including Stephan Georg Mueller and Klaus Rudolf. These partnerships have enhanced his research output, allowing for the exchange of cutting-edge ideas and expertise in the development of novel therapeutic approaches.
Conclusion
Fabio Paleari's work exemplifies the spirit of innovation within the pharmaceutical industry. Through his numerous patents and collaborative efforts, he continues to pave the way for advancements in healthcare solutions, particularly in the realm of CNS disorders. His contributions are vital in the ongoing pursuit of effective pharmaceuticals that cater to the complexities of human health.